DHR · 8-K · 20260803PR330652

Leadership Transition

DANAHER CORP /DE/ · 2026-08-03 · Importance 44 · Surprise 60

Danaher appointed Julie Sawyer Montgomery as President and Chief Executive Officer and a member of the Board, effective October 1, 2026. Rainer Blair will retire on the same date and remain as a senior advisor through March 31, 2027, supporting the transition. The company also announced special equity incentive awards for key leadership members and founders in connection with the appointment.

Key facts

• Danaher's Board of Directors has appointed Julie Sawyer Montgomery as President and Chief Executive Officer and a member of the Board of Directors, effective October 1, 2026. source
• On October 1, 2026, Rainer Blair will retire and serve as a senior advisor until March 31, 2027 to ensure a seamless transition. source
• Danaher announced special equity incentive awards for key leadership members and founders in conjunction with Julie Sawyer Montgomery’s appointment. source
• Julie Sawyer Montgomery led the recent acquisition of Masimo. source
• Julie Sawyer Montgomery joined Danaher in 2017 at Beckman Coulter Diagnostics, where she led commercial operations and R&D before becoming President in 2020. source
• Julie Sawyer Montgomery has nearly 25 years of experience across healthcare, commercial operations, and R&D. source
• Julie Sawyer Montgomery most recently served as Executive Vice President of Danaher, with responsibility for the Diagnostics platform. source
• Steven Rales said Rainer Blair led Danaher over the past six years. source